TGF-beta induced Erk phosphorylation of smad linker region regulates smad signaling

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Hough, Chris ^a   Radu, Maria ^b   Doré, Jules J E ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; P21 ACTIVATED KINASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; RAF PROTEIN; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIVISION; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM CELL; FIBROBLAST; GENETIC TRANSCRIPTION; HALF LIFE TIME; HUMAN; HUMAN CELL; MESENCHYME CELL; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; MICE; MODELS, BIOLOGICAL; P21-ACTIVATED KINASES; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-RAF; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFORMING GROWTH FACTOR BETA;

EID: 84864647706     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042513     Document Type: Article

References (52)

1. Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF, ((1992)) Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775-785.
2. Franzen P, Ten Dijke P, Ichijo H, Yamashita H, Schulz P, et al. ((1993)) Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell 75:681-692.
3. Zhang Y, Feng X, We R, Derynck R, ((1996)) Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature 383:168-172.
4. Zhang Y, Musci T, Derynck R, ((1997)) The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function. Curr Biol 7:270-276.
5. Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL, ((1996)) MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87:1215-1224.
6. Baker JC, Harland RM, ((1996)) A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev 10:1880-1889.
7. Blanchette F, Rivard N, Rudd P, Grondin F, Attisano L, Dubois CM, ((2001)) Cross-talk between the p42/p44 MAP kinase and smad pathways in transforming growth factor β1-induced furin gene transactivation. J Biol Chem 276:33986-33994.
8. Wang W, Zhou G, Hu MC, Yao Z, Tan TH, ((1997)) Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor beta (TGF-beta)-activated kinase (TAK1), a kinase mediator of TGF beta signal transduction. J Biol Chem 272:22771-22775.
9. Kamaraju AK, Roberts AB, ((2005)) Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo. J Biol Chem 280:1024-1036.
10. Wilkes MC, Murphy SJ, Garamszegi N, Leof EB, ((2003)) Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3. Mol Cell Biol 23:8878-8889.
11. Wilkes MC, Repellin CE, Hong M, Bracamonte M, Penheiter SG, et al. ((2009)) Erbin and the NF2 tumor suppressor merlin cooperatively regulate cell-type-specific activation of PAK2 by TGF-β. Devel Cell 16:433-444.
12. Wilkes MC, Mitchell H, Penheiter SG, Dore JJ, Suzuki K, et al. ((2005)) Transforming growth factor-beta activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2. Cancer Res 65:10431-10440.
13. Suzuki K, Wilkes MC, Garamszegi N, Edens M, Leof EB, ((2007)) Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses. Cancer Res 67:3673-3682.
14. Hofmann C, Shepelev M, Chernoff J, ((2004)) The genetics of Pak. J Cell Sci 117:4343-4354.
15. Dan I, Watanabe NM, Kusumi A, ((2001)) The Ste20 group kinases as regulators of MAP kinase cascades. Trends Cell Biol 11:220-230.
16. Coles LC, Shaw PE, ((2002)) PAK1 primes MEK1 for phosphorylation by Raf-1 kinase during cross-cascade activation of the ERK pathway. Oncogene 21:2236-2244.
17. Park ER, Eblen ST, Catling AD, ((2007)) MEK1 activation by PAK: a novel mechanism. Cell Signal 19:1488-1496.
18. Kretzschmar M, Doody J, Timokhina I, Massague J, ((1999)) A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev 13:804-816.
19. Lo RS, Wotton D, Massague J, ((2001)) Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF. EMBO J 20:128-136.
20. Chen C, Sytkowski AJ, ((2004)) Erythropoietin regulation of Raf-1 and MEK: evidence for a ras-independent mechanism. Blood 104:73-80.
21. Beeser A, Jaffer ZM, Hofmann C, Chernoff J, ((2005)) Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors. J Biol Chem 280:36609-36615.
22. Kretzschmar M, Doody J, Massague J, ((1997)) Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 389:618-622.
23. Burch ML, Yang SNY, Ballinger ML, Getachew R, Osman N, Little PJ, ((2010)) TGF-b stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of smad2. Cell Mol Life Sci 67:2077-2090.
24. Matsurra I, Wang G, He D, Liu F, ((2005)) Identification and characterization of ERK MAP kinase phosphorylation sites in smad3. Biochem 44:12546-12553.
25. Alarcon C, Zaromytidou A-I, Xi Q, Gao S, Yu J, et al. ((2009)) Nuclear CDKs drive smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell 139:757-769.
26. Yue J, Frey RS, Mulder KM, ((1999)) Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFbeta. Oncogene 18:2033-2037.
27. Grimm OH, Gurbon JB, ((2002)) Nuclear exclusion of smad 2 is a mechanism leading to loss of competence. Nat Cell Biol 4:519-522.
28. Gao S, Alarcon C, Sapkota G, Rahman S, Chen P-Y, et al. ((2009)) Ubiquitin ligase Nedd4L targets activated smad2/3 to limit TGF-β signaling. Mol Cell 36:457-468.
29. Liu Y, Dore JJE, Chen X, ((2007)) Calcium influx through L-type channels generates protein kinase M to induce burst firing of dopamine cells in the rate ventral tegmental area. J Biol Chem 282:8594-8603.
30. Wharton W, Leof E, Pledger WJ, O'Keefe EJ, ((1982)) Modulation of the epidermal growth factor receptor by platelet-derived growth factor and choleragen: effects on mitogenesis. Proc Natl Acad Sci USA 79:5567-5571.
31. Pfaffl MW, ((2001)) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
32. Guyton KZ, Liu Y, Gorospe M, Xu Q, Holbrook NJ, ((1996)) Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury. J Biol Chem 271:4138-4142.
33. Jakobi R, Moertl E, Koeppel MA, ((2001)) p21-activated protein kinase gamma-PAK suppresses programmed cell death of BALB3T3 fibroblasts. J Biol Chem 276:16624-16634.
34. Diaz B, Barnard D, Filson A, MacDonald S, King A, Marshall M, ((1997)) Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biological signaling. Mol Cell Biol 17:4509-4516.
35. King AJ, Sun H, Diaz B, Barnard D, Miao W, et al. ((1998)) The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338. Nature 396:180-183.
36. Manne V, Ricca CS, Brown JG, Tuomari AV, Yan N, et al. ((1995)) Ras farnesylation as a target for novel antitumour agents: Potent and selective farnesyl diphosphate analog inhibitors of farnesyltransferase. Drug Devel Res 34:121-137.
37. Lo RS, Massague J, ((1999)) Ubiquitin-dependent degradation of TGF-beta-activated smad2. Nat Cell Biol 1:472-478.
38. Massague J, Seoane J, Wotton D, ((2005)) Smad transcription factors. Genes Dev 19:2783-2810.
39. Gille H, Kortenjann M, Thomae O, Moomaw C, Slaughter C, et al. ((1995)) ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J 14:951-962.
40. Weber JD, Raben DM, Phillips PJ, Baldassare JJ, ((1997)) Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J 326:61-68.
41. Sears R, Leone G, DeGregori J, Nevins JR, ((1999)) Ras enhances Myc protein stability. Mol Cell 3:169-179.
42. Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR, ((2000)) Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 14:2501-2514.
43. Mucsi I, Skorecki KL, Goldberg HJ, ((1996)) Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-beta1 on gene expression. J Biol Chem 271:16567-16572.
44. Atfi A, Djelloul S, Chastre E, Davis R, Gespach C, ((1997)) Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor beta-mediated signaling. J Biol Chem 272:1429-1432.
45. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL, ((2000)) Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275:36803-36810.
46. Bhowmick NA, Ghiassi M, Bakin A, Aakre M, Lundquist CA, et al. ((2001)) Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 12:27-36.
47. Chaudhary A, King WG, Mattaliano MD, Frost JA, Diaz B, et al. ((2000)) Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338. Curr Biol 10:551-554.
48. Inman GJ, ((2005)) Linking smads and transcriptional activation. Biochem J 386:e1-e3.
49. Cohen-Solal KA, Merrigan KT, Chan JL-K, Goydos JS, Chen W, et al. ((2011)) Constitutive smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-β-medicated growth inhibition. Pigment Cell Melanoma Res 24:512-524.
50. Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH, Massague J, ((2007)) Balancing BMP signaling through integrated inputs into smad1 linker. Mol Cell 25:441-454.
51. Penheiter SG, Mitchell H, Garamszegi N, Edens M, Dore JJE, Leof EB, ((2002)) Internalization-dependent and-independent requirements for transforming growth factor β receptor signaling via the smad pathway. Mol Cell Biol 22:4750-4759.
52. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL, ((2003)) Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 5:410-421.